• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper
 
  • Details
  • Full
Options
2026
Journal Article
Title

Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper

Abstract
Mast cell disorders (MCD), including mastocytosis and mast cell (MC) activation syndrome (MCAS), encompass a heterogeneous spectrum of diseases often presenting with debilitating manifestations. Variable clinical manifestations, ranging from otherwise asymptomatic cutaneous forms to recurrent anaphylaxis, pose significant challenges for timely diagnosis and effective management. Despite increasing recognition of MCD in Europe, diagnosis is frequently delayed, and therapeutic approaches remain inconsistent, potentially due to gaps and disparities in training. An European Academy of Allergy and Clinical Immunology (EAACI) Task Force (TF) was created to address this need. Through iterative consensus, the TF members formulated ten expert-based recommendations outlining the minimum competencies that allergology and clinical immunology trainees should acquire regarding MCD. These include fundamental knowledge of MC biology, pathogenesis of clonality, recognition of systemic manifestations, diagnostic methodologies, pharmacological and preventive strategies, management of comorbid Hymenoptera venom allergy, pediatric aspects, communication skills, and how to acquire and consolidate expertise. This position paper underscores the need for harmonized competency-based training competencies on MCD for Allergists and Clinical Immunologists across Europe. We advocate for the incorporation of these recommendations into national postgraduate curricula, aiming to foster earlier recognition, improve management, and ultimately enhance long-term outcomes for MCD patients.
Author(s)
Rama, Tiago Azenha
Unidade Local de Saúde de Matosinhos
Gülen, Theo
Karolinska Universitetssjukhuset
Brockow, Knut
Klinikum Rechts der Isar
Bonadonna, Patrizia
Azienda Ospedaliera Universitaria Integrata Verona
Sabato, Vito
Universiteit Antwerpen
Grattan, Ceh E.H.
St John's Institute of Dermatology
Broesby-Olsen, Sigurd
Odense Universitetshospital
Altrichter, Sabine
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP  
Siebenhaar, Frank
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Walusiak-Skorupa, Jolanta Magdalena
Instytut Medycyny Pracy im. Prof. J. Nofera
González-De-Olano, David G.
Hospital Universitario Ramón y Cajal
Journal
Allergy. European journal of allergy and clinical immunology  
DOI
10.1111/all.70344
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • competencies

  • education

  • mast cell activation syndrome

  • mast cell disorders

  • mastocytosis

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024